Jane Street’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Jane Street's XGN Position: Q2 2026 in Review
Jane Street increased its Exagen (XGN) stake by 36% in Q2 2026, buying an estimated $323K and bringing the position to 322,502 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #5700.
Jane Street first reported a position in XGN in Q3 2025 and has held it in 4 quarters since. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Jane Street held 322,502 shares of Exagen worth $1.5M as of Q2 2026.
- Jane Street bought 85,767 Exagen shares in Q2 2026, an estimated $323K.
- Exagen made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5700 holding.
- Jane Street first reported a position in Exagen in Q3 2025 and has held it in 4 quarters since.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.